- Home
- NYT vs RVTY Comparison
NYT vs RVTY Comparison
Compare NYT & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NYT | RVTY |
|---|---|---|
| Founded | 1851 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Newspapers/Magazines | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 12.7B |
| IPO Year | 1994 | 1994 |
Fundamental Metrics
Financial Performance| Metric | NYT | RVTY |
|---|---|---|
| Price | $72.50 | $144.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 16 |
| Target Price | $72.14 | ★ $109.67 |
| AVG Volume (30 Days) | ★ 1.8M | 1.7M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.16% | 0.34% |
| EPS Growth | ★ 18.08 | N/A |
| EPS | ★ 1.11 | 0.82 |
| Revenue | $1,783,639,000.00 | ★ $3,311,822,000.00 |
| Revenue This Year | $10.58 | $6.37 |
| Revenue Next Year | $6.98 | $5.10 |
| P/E Ratio | ★ $64.60 | $170.96 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $54.10 | $81.22 |
| 52 Week High | $87.10 | $133.00 |
Technical Indicators
Market Signals| Indicator | NYT | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 63.15 | 70.72 |
| Support Level | $69.30 | $95.31 |
| Resistance Level | $72.32 | N/A |
| Average True Range (ATR) | 1.59 | 4.19 |
| MACD | 0.57 | 0.19 |
| Stochastic Oscillator | 77.46 | 99.84 |
Price Performance
Historical ComparisonAbout NYT New York Times Company (The)
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company derives revenue from subscriptions, advertising, and other sources, where the majority of its revenue is generated through subscriptions, which consist of income from standalone and multiproduct bundle subscriptions to its digital products and subscriptions to and single-copy and bulk sales of print products.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.